glp-1 kidney cancer receptor agonists and risk in adults with obesity: A new chapter in metabolic oncology? Emerging Evidence Positions GLP-1 Receptor

The expression of GLP-1R on various cell types and its impact on the neurovascular unit (NVU), including neurons, glial cells, and endothelial cells, make GLP-1 a strong candidate for bridging brain-body crosstalk

Establish a hydration habit before starting

however, IL-1 was almost undetectable in plasma samples [125]

Regular medication-related vomiting goes away quickly

71% stop taking GLP-1s by 12 months 6 74% report gastrointestinal symptoms 7 65% report NO increased exercise after starting medication 8 This is why the Noom GLP-1 Rx Program with Noom GLP-1 Companion exists

This study, the first of its kind, examines the effects of GLP-1RAs like semaglutide (Ozempic) and compares them with other widely used antihyperglycemic agents